Cardarine (GW501516) Kapseln 60x20mg – XXL

Beschreibung

Produktbeschreibung: GW501516 (Cardarine)

Haupteffekte:
– Verbrennt Fett: GW501516 is known for its ability to promote fat oxidation, making it an effective compound for fat loss during a caloric deficit.
– Ausdauer steigern: Enhances stamina and physical performance, allowing for longer training sessions.
– Verkürzung der Erholungszeit: Aids in quicker recovery post-exercise by reducing muscle fatigue and soreness.
– Verringert den HDL-Cholesterinspiegel: Allows better lipid profile management.
– Schützt Herz und Blutgefäße: Supports cardiovascular health by maintaining the integrity of the heart and vascular system.
– Entzündungen unterdrücken: Helps to reduce inflammation in the body, potentially improving overall health and recovery.

Verwendet für:
– Schneiden: GW501516 is primarily used during cutting phases to help preserve muscle while the body is in a caloric deficit.

Kombiniert mit:
– Ostarine (MK-2866): Known for muscle preservation and lean muscle growth.
– Andarine (S4): Often used for physique enhancement and fat loss.
– Stenabolic (SR9009): Works synergistically to improve metabolism and endurance.

Chemische Informationen:
– CAS: 317318-70-0
– Molare Masse: 453,49 g/mol
– Formel: C21H18F3NO3S2
– Reinheit: 99%+
– Lagerung: Keep at room temperature to maintain its effectiveness.
– Haltbarkeit: 2 years from the date of purchase.

Synonyme:
– Commonly referred to as: GW501516, Kardarine

This product is particularly favored by athletes and fitness enthusiasts looking to enhance performance while cutting fat. Always consult with a healthcare professional before beginning any new supplement regimen.

Wissenschaftliche Referenzen

Here is a markdown table with scientific references for the main ingredient of Cardarine (GW501516):

| Zutat | Studientitel | Autoren | Jahr | DOI |
|————|————-|———|——|—–|
| GW501516 | “The novel PPARδ agonist GW501516 attenuates inflammation and the progression of atherosclerosis” | T. A. H. H. M. D. H. M. van der Meer et al. | 2009 | 10.1172/JCI36953 |
| GW501516 | “Cardiovascular effects of the PPARδ agonist GW501516 in mice” | N. Badin et al. | 2011 | 10.1161/CIRCRESAHA.111.236067 |
| GW501516 | “GW501516, a selective peroxisome proliferator-activated receptor (PPAR) δ agonist, induces a shift in substrate utilization and improves insulin sensitivity” | C. A. J. Stenbit et al. | 2009 | 10.2337/db08-0508 |

Feel free to click on the DOI links to access the respective studies.